Lexeo Therapeutics ($LXEO) Insider Trading & Smart Money Activity
Lexeo Therapeutics, Inc. ($LXEO) has 5 insider trades, 2 13F position changes and 1 analyst rating on file. Insiders filed 5 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 1
LXEO insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 2 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All LXEO insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analyst | JP Morgan | Reiterates to buy | PT $9 | -0.2% | -4.9% | Read | |||||
| Insider | Van Hauwermeiren Timothy | Buy (Grant or award) | 35K sh | -0.2% | -4.9% | — | |||||
| Insider | Tolga Tanguler | Buy (Grant or award) | 35K sh | -0.2% | -4.9% | Read | |||||
| Insider | Brenda Cooperstone | Buy (Grant or award) | 35K sh | -0.2% | -4.9% | Read | |||||
| Insider | Steven Altschuler | Buy (Grant or award) | 35K sh | -0.2% | -4.9% | — | |||||
| Insider | Agger Mette Kirstine | Buy (Grant or award) | 35K sh | -0.2% | -4.9% | Read | |||||
| 13F | Avoro Capital Advisors | Reduced | -1.43M sh | $8.19M | +0.4% | -8.6% | Read | ||||
| 13F | Avoro Capital Advisors | Reduced | -1.43M sh | $9.02M | +0.4% | -8.6% | Read |
1W / 1M / 6M = how LXEO moved from the trade or filing date.
Insider trading in LXEO: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Van Hauwermeiren Timothy | 1 | — | Jun 25, 2026 | ||
| Tolga Tanguler | 1 | — | Jun 25, 2026 | ||
| Brenda Cooperstone | 1 | — | Jun 25, 2026 | ||
| Steven Altschuler | 1 | — | Jun 25, 2026 | ||
| Agger Mette Kirstine | 1 | — | Jun 25, 2026 |
Institutions moving LXEO (13F)
Analyst ratings on LXEO
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| JP Morgan | Reiterates | buy | $9 | -0.2% | -4.9% | Read |
Frequently asked questions
What is the latest insider trade in LXEO?
Van Hauwermeiren Timothy filed a buy (grant or award) of 35K sh on Jun 25, 2026.
Which institutions changed their LXEO positions?
Recent 13F filers moving the stock include Avoro Capital Advisors.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.